
Mustang Bio (MBIO) Stock Explodes 260% After FDA Grants Key Cancer Drug Designation
Mustang Bio Inc MBIO shares are trading sharply higher Monday afternoon. The company earlier saw a positive development as the FDA granted Orphan Drug Designation to its cell therapy candidate, MB-101. Here’s what investors need to know. What To Know: This …